Unintentional Weight Loss Evaluation
Confirm it, check the basics, and resist the whole-body scan.
Definition and first steps
What counts. Losing more than 5% of body weight over 6–12 months without trying is clinically significant and is associated with higher morbidity and mortality, particularly in older adults. Confirm the loss with documented prior weights, because patients' estimates are unreliable, and make sure it is not intentional dieting.
Appetite as a branch point. Weight loss despite a preserved or increased appetite suggests a hypermetabolic or malabsorptive state — hyperthyroidism, uncontrolled diabetes, malabsorption, or pheochromocytoma. Weight loss with a poor appetite points toward malignancy, depression, chronic organ failure, or drug effects.
Differential diagnosis
Malignancy, nonmalignant gastrointestinal disease, and psychiatric illness are the most common identifiable causes, yet in roughly a quarter of patients no cause is found even after a thorough evaluation. In older adults, reversible nonmalignant causes such as depression, medications, and social barriers are especially common.
| Category | Examples | Clues |
|---|---|---|
| Malignancy | GI, pancreatic, lung, lymphoma | Night sweats, anemia, smoking, early satiety |
| GI disease | Celiac disease, chronic pancreatitis, peptic ulcer, dysphagia | Steatorrhea, postprandial pain, fear of eating |
| Endocrine | Hyperthyroidism, uncontrolled diabetes, adrenal insufficiency | Increased appetite, polyuria, hyperpigmentation with low Na and high K |
| Psychiatric and cognitive | Depression, dementia | Anhedonia, insomnia, forgotten meals |
| Chronic infection | HIV, tuberculosis, hepatitis C, endocarditis, parasites | Fever, night sweats, exposures, risk factors |
| Organ failure | Heart failure, COPD, CKD | Known chronic disease, cachexia |
| Drugs and substances | Digoxin, metformin, GLP-1 agonists, SGLT2 inhibitors, topiramate, SSRIs, cholinesterase inhibitors, excess levothyroxine, stimulants, alcohol, tobacco, cocaine, amphetamines | Loss began after a new drug; polypharmacy |
| Social | Poverty, poor dentition, isolation, functional decline, neglect | Lives alone, recent bereavement, ill-fitting dentures, cannot shop or cook |
Specific clues. Adrenal insufficiency brings anorexia, fatigue, hyperpigmentation, hyponatremia, and hyperkalemia (check morning cortisol and ACTH); older adults with hyperthyroidism may be apathetic rather than hyperactive. Depression in late life often presents with somatic complaints and weight loss instead of reported sadness, and dementia reduces intake through forgotten meals, apraxia, and dysphagia. Sitophobia — avoiding food because eating causes pain, as with gastric ulcers or chronic mesenteric ischemia — produces weight loss despite intact hunger. Anticholinergic drugs cause dry mouth and altered taste, and overly restrictive therapeutic diets (low-salt, low-fat, diabetic) make food unappealing.
The 9 Ds of weight loss in older adults: dentition, dysgeusia, dysphagia, diarrhea, depression, disease, dementia, dysfunction, and drugs.
Initial evaluation
- HistoryDiet and intake, appetite, GI and constitutional symptoms, mood (PHQ-2/PHQ-9) and cognition, all medications and substances, finances, living situation.
- ExaminationWeight trend, mouth and dentition, thyroid, lymph nodes, heart and lungs, abdomen, rectal exam, and a cognitive screen.
- Baseline testsCBC, comprehensive metabolic panel, TSH, HbA1c, ESR or CRP, urinalysis, HIV, HCV, and chest x-ray.
- Cancer screeningBring age-appropriate screening up to date: colonoscopy, mammography, cervical screening, low-dose chest CT if eligible.
- Targeted testingPursue specific abnormalities, such as endoscopy for dysphagia or celiac serology for diarrhea.
When everything is normal. A normal history, examination, and baseline panel make serious organic disease unlikely. The preferred strategy is watchful waiting — repeat the weight and reassess in 1–6 months — rather than blind CT of the chest, abdomen, and pelvis, PET scanning, or tumor markers, which add cost, radiation, and false positives without improving outcomes.
Management
Treat the cause and support intake. Address the underlying disease, deprescribe drugs that suppress appetite or alter taste, liberalize unnecessary dietary restrictions, and offer oral nutritional supplements between meals so they add calories without replacing the meal. Arrange dental care, help with feeding and preferred foods, and connect patients with meal-delivery programs and social services.
| Agent | Effect | Main concerns |
|---|---|---|
| Megestrol acetate | Modest gain, mostly fat and fluid; no functional benefit | VTE, adrenal suppression, edema, possibly higher mortality; Beers list |
| Dronabinol | Stimulates appetite | Confusion, dizziness, sedation in older adults |
| Mirtazapine | Improves appetite and sleep | Use when depression coexists; sedation, falls |
Megestrol is on the Beers list of drugs to avoid in older adults: it raises thromboembolic risk and adds little meaningful weight.